Giving Alzheimer's the Old One-Two
Author(s) -
Michael S. Wolfe,
Dennis J. Selkoe
Publication year - 2010
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2010.07.006
Subject(s) - biology , amyloid precursor protein secretase , peptide , amyloid precursor protein , alzheimer's disease , transcription factor , amyloid (mycology) , retinoic acid , disease , microbiology and biotechnology , neuroscience , cancer research , biochemistry , medicine , gene , botany
A dual goal for treating Alzheimer's disease (AD) is to decrease deposition of neurotoxic amyloid beta-peptide in the brain and to boost repair of damaged neurons. Donmez et al. (2010) now show that SIRT1 may mediate both processes by deacetylating the transcription factor retinoic acid receptor beta, a potential new therapeutic target for AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom